# agilon health, inc.: filings

AGL · NYSE · CIK 1831097 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/agl.md) · [Financials](/companies/agl/financials.md) · [Filings](/companies/agl/filings.md) · [Insiders](/companies/agl/insiders.md)

## Reports and events: 89 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 210, 8-K 56, 3 28, 10-Q 17, SC 13G/A 12, SCHEDULE 13G/A 12, 4/A 11, DEFA14A 9, 144 7, CORRESP 7, DEF 14A 6, UPLOAD 6, 10-K 5, SC 13G 5, SCHEDULE 13G 4, ARS 3, 424B4 2, 424B7 2, DRS 2, DRSLTR 2, EFFECT 2, S-1 2, S-1/A 2, 10-K/A 1, 8-A12B 1, CERT 1, DRS/A 1, FWP 1, PRE 14A 1, S-3ASR 1, S-8 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 16:11 ET | [10-Q](/filings/0001628280-26-053355.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053355 |
| 2026-08-05 | 16:07 ET | [8-K](/filings/0001628280-26-053328.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053328 |
| 2026-07-22 | 17:51 ET | [8-K](/filings/0001628280-26-049080.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-049080 |
| 2026-06-03 | 16:31 ET | [8-K](/filings/0001628280-26-040370.md) | 5.07 Shareholder vote results | 0001628280-26-040370 |
| 2026-05-06 | 16:11 ET | [10-Q](/filings/0001628280-26-031270.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031270 |
| 2026-05-06 | 16:07 ET | [8-K](/filings/0001628280-26-031254.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031254 |
| 2026-04-27 | 16:18 ET | [8-K](/filings/0001628280-26-027512.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-027512 |
| 2026-04-22 | 16:49 ET | [DEF 14A](/filings/0001628280-26-026544.md) | Proxy statement, period 2026-06-02 | 0001628280-26-026544 |
| 2026-03-30 | 17:43 ET | [8-K](/filings/0001628280-26-022074.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-26-022074 |
| 2026-03-18 | 16:06 ET | [8-K](/filings/0001628280-26-019406.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-019406 |
| 2026-02-25 | 16:12 ET | [10-K](/filings/0001628280-26-011655.md) | Annual report, period 2025-12-31 | 0001628280-26-011655 |
| 2026-02-25 | 16:07 ET | [8-K](/filings/0001628280-26-011630.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-011630 |
| 2026-02-18 | 16:24 ET | [DEF 14A](/filings/0001140361-26-006007.md) | Proxy statement, period 2026-03-17 | 0001140361-26-006007 |
| 2026-02-12 | 16:09 ET | [8-K](/filings/0001628280-26-007671.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-007671 |
| 2026-01-07 | 16:10 ET | [8-K](/filings/0001628280-26-001168.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-001168 |
| 2025-11-07 | 07:03 ET | [8-K](/filings/0001628280-25-050412.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-050412 |
| 2025-11-04 | 16:12 ET | [10-Q](/filings/0001628280-25-048839.md) | Quarterly report, period 2025-09-30 | 0001628280-25-048839 |
| 2025-11-04 | 16:09 ET | [8-K](/filings/0001628280-25-048815.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-048815 |
| 2025-08-04 | 16:15 ET | [10-Q](/filings/0001628280-25-037430.md) | Quarterly report, period 2025-06-30 | 0001628280-25-037430 |
| 2025-08-04 | 16:12 ET | [8-K](/filings/0001628280-25-037426.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure | 0001628280-25-037426 |
| 2025-05-30 | 16:43 ET | [8-K](/filings/0001628280-25-028631.md) | 5.07 Shareholder vote results | 0001628280-25-028631 |
| 2025-05-06 | 16:12 ET | [10-Q](/filings/0001628280-25-022691.md) | Quarterly report, period 2025-03-31 | 0001628280-25-022691 |
| 2025-05-06 | 16:08 ET | [8-K](/filings/0001628280-25-022679.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-022679 |
| 2025-04-17 | 17:05 ET | [DEF 14A](/filings/0001140361-25-014418.md) | Proxy statement, period 2025-05-28 | 0001140361-25-014418 |
| 2025-02-25 | 16:06 ET | [10-K](/filings/0001628280-25-007721.md) | Annual report, period 2024-12-31 | 0001628280-25-007721 |
| 2025-02-25 | 16:02 ET | [8-K](/filings/0001628280-25-007716.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-007716 |
| 2024-12-05 | 16:02 ET | [8-K](/filings/0001628280-24-050056.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-050056 |
| 2024-11-19 | 08:00 ET | [8-K](/filings/0001628280-24-048345.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-048345 |
| 2024-11-07 | 16:16 ET | [10-Q](/filings/0001628280-24-046286.md) | Quarterly report, period 2024-09-30 | 0001628280-24-046286 |
| 2024-11-07 | 16:11 ET | [8-K](/filings/0001628280-24-046267.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-046267 |
| 2024-08-06 | 16:08 ET | [10-Q](/filings/0001628280-24-035179.md) | Quarterly report, period 2024-06-30 | 0001628280-24-035179 |
| 2024-08-06 | 16:04 ET | [8-K](/filings/0001628280-24-035171.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-035171 |
| 2024-06-05 | 08:05 ET | [8-K](/filings/0001628280-24-026758.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-026758 |
| 2024-06-03 | 16:15 ET | [8-K](/filings/0001628280-24-026327.md) | 5.07 Shareholder vote results | 0001628280-24-026327 |
| 2024-05-07 | 16:09 ET | [10-Q](/filings/0001628280-24-021088.md) | Quarterly report, period 2024-03-31 | 0001628280-24-021088 |
| 2024-05-07 | 16:05 ET | [8-K](/filings/0001628280-24-021075.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-021075 |
| 2024-04-18 | 17:07 ET | [DEF 14A](/filings/0001140361-24-020533.md) | Proxy statement, period 2024-05-29 | 0001140361-24-020533 |
| 2024-02-27 | 16:22 ET | [10-K](/filings/0001628280-24-007242.md) | Annual report, period 2023-12-31 | 0001628280-24-007242 |
| 2024-02-27 | 16:03 ET | [8-K](/filings/0001628280-24-007195.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-007195 |
| 2024-02-08 | 16:07 ET | [8-K](/filings/0001628280-24-003867.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-003867 |
| 2024-01-05 | 06:08 ET | [8-K](/filings/0001628280-24-000518.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-000518 |
| 2024-01-05 | 06:02 ET | [8-K](/filings/0001628280-24-000516.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-000516 |
| 2023-11-14 | 07:58 ET | [8-K](/filings/0001628280-23-038794.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-038794 |
| 2023-11-02 | 16:03 ET | [10-Q](/filings/0001628280-23-036378.md) | Quarterly report, period 2023-09-30 | 0001628280-23-036378 |
| 2023-11-02 | 16:01 ET | [8-K](/filings/0001628280-23-036376.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-036376 |
| 2023-08-16 | 16:15 ET | [8-K](/filings/0001193125-23-214326.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-214326 |
| 2023-08-08 | 17:09 ET | [10-K/A](/filings/0001628280-23-028276.md) | Annual report, amended, period 2022-12-31 | 0001628280-23-028276 |
| 2023-08-03 | 16:08 ET | [10-Q](/filings/0001628280-23-027201.md) | Quarterly report, period 2023-06-30 | 0001628280-23-027201 |
| 2023-08-03 | 16:04 ET | [8-K](/filings/0001628280-23-027194.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-027194 |
| 2023-06-26 | 09:00 ET | [8-K](/filings/0001019056-23-000285.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001019056-23-000285 |

Page 1 of 2. [Older](/companies/agl/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.